Insight Molecular Diagnostics Inc. (IMDX) Debt Components
- 2023-09-30: Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2023-06-30: Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2023-03-31: Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
- 2022-12-31: Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m); Long-Term Debt, Maturity, Year ThreeUSD (m).
Insight Molecular Diagnostics Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Line of Credit Facility, Interest Rate at Period End pure | Long-term Debt, Gross USD | Debt Instrument, Decrease, Forgiveness USD |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | (m) | (m) | (m) | (m) | 5.50% | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | 5.50% | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | 5.50% | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | 5.50% | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | 6.25% | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | 4.75% | (m) | (m) |
| 2022-04-13 | (m) | (m) | (m) | (m) | (m) | (m) | $15.00M |
| 2022-03-31 | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
| 2019-12-31 | (m) | $1.26M | $1.56M | $578.00K | (m) | $3.20M | (m) |
| 2018-12-31 | (m) | $843.00K | $386.00K | (m) | (m) | $1.18M | (m) |
| 2017-12-31 | $1.87M | $876.00K | $835.00K | $386.00K | (m) | $2.10M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |